Preferred Label : naldemedine;
MeSH synonym : 17-(cyclopropylmethyl)-6,7-didehydro-4,5alpha-epoxy-3,6,14-trihydroxy-N-(2-(3-phenyl-
1,2,4-oxadiazol-5-yl)propan-2-yl)morphinan-7-carboxamide;
UNII : 03KSI6WLXH;
Origin ID : C000620491;
UMLS CUI : C4325235;
ATC code(s)
- Currated CISMeF NLP mapping
- Manual BTNT mappings - CISMeF
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3473438/fr/rizmoic-naldemedine-constipation-induite-par-les-opioides-cio
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, oral
Naldemedine Tosylate
magnesium stearate
adult
evaluation of the transparency committee
Opioid-Induced Constipation
naldemedine
---
https://www.has-sante.fr/jcms/p_3323281/fr/rizmoic-naldemedine
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
naldemedine
naldemedine
Opioid-Induced Constipation
adult
administration, oral
Product containing only naldemedine in oral dose form (medicinal product form)
evaluation of the transparency committee
naldemedine
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rizmoic
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
naldemedine
naldemedine
analgesics, opioid
administration, oral
receptors, opioid, kappa
receptors, opioid, delta
receptors, opioid, mu
product surveillance, postmarketing
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
naldemedine
Opioid-Induced Constipation
naltrexone
naltrexone
naltrexone
---
